Edition:
United States

Vita 34 AG (V3VGn.DE)

V3VGn.DE on Xetra

12.00EUR
11:36am EDT
Change (% chg)

€0.64 (+5.68%)
Prev Close
€11.35
Open
€11.50
Day's High
€12.69
Day's Low
€11.49
Volume
59,455
Avg. Vol
17,481
52-wk High
€12.69
52-wk Low
€4.43

Latest Key Developments (Source: Significant Developments)

Vita 34 says Falk Neukirch CFO again from Sept. 11
Friday, 8 Sep 2017 07:15am EDT 

Sept 8 (Reuters) - VITA 34 AG ::DGAP-NEWS: VITA 34 COMPLETES MANAGEMENT BOARD WITH THE RETURN OF FALK NEUKIRCH.FALK NEUKIRCH CFO OF VITA 34 AG AGAIN FROM 11 SEPTEMBER.‍PERSONNEL CHANGES IN MANAGEMENT AND SUPERVISORY BOARD COMPLETED​.  Full Article

Vita 34 H1 net result swings to loss of EUR 1.0 mln
Wednesday, 30 Aug 2017 01:15am EDT 

Aug 30 (Reuters) - VITA 34 AG ::H1 REVENUE INCREASED BY 2.5 PERCENT AND GROSS PROFIT BY 14 PERCENT AS COMPARED WITH H1 2016.PROFIT BURDENED THIS YEAR BY ONE-TIME EFFECT OF SERACELL ACQUISITION.H1 ‍GROSS PROFIT FROM SALES INCREASED BY 14 PERCENT TO EUR 4.6 MILLION (H1 2016: EUR 4.0 MILLION)​.IN FIRST SIX MONTHS REVENUES ROSE TO NEARLY EUR 8.2 MILLION.OUTLOOK 2017: EXPECTS REVENUES OF EUR 18.9 TO 19.4 MILLION (TO DATE: EUR 17.4 TO 17.9 MILLION).OUTLOOK 2017: EXPECTS EBITDA OF EUR 1.6 TO 1.9 MILLION (TO DATE: EUR 2.6 TO 2.7 MILLION).PERIOD RESULT IN FIRST HALF-YEAR 2017 DECREASED TO EUR -1.0 MILLION (H1 2016: EUR 0.1 MILLION).FROM 2018 ONWARD WE EXPECT NO FURTHER PROFIT BURDENING SPECIAL EFFECTS FROM ACQUISITION OF SERACELL.  Full Article

Vita 34 adjusts revenues and earnings targets for 2017
Tuesday, 8 Aug 2017 05:04am EDT 

Aug 8 (Reuters) - VITA 34 AG ::DGAP-ADHOC: VITA 34 ADJUSTS REVENUES AND EARNINGS TARGETS FOR 2017.‍FROM 2018 ONWARDS, MANAGEMENT EXPECTS NO FURTHER SPECIAL EFFECTS RESULTING FROM ACQUISITION OF SERACELL​.‍FY OUTLOOK: NOW EXPECTS EBITDA BETWEEN EUR 1.6 TO 1.9 MILLION (PREVIOUSLY: EUR 2.6 - 2.7 M).​.NOW EXPECTS FY REVENUES BETWEEN EUR 18.9 AND 19.4 MILLION (PREVIOUSLY: EUR 17.4 - 17.9 M).ADJUSTS ITS OUTLOOK FOR CURRENT FINANCIAL YEAR AFTER ACQUISITION OF FORMER COMPETITOR SERACELL.  Full Article

VITA 34 resolves on cash capital increase
Tuesday, 11 Jul 2017 01:24am EDT 

July 11 (Reuters) - VITA 34 AG ::SAID ON MONDAY VITA 34 AG RESOLVES TO IMPLEMENT RIGHTS ISSUE AGAINST CASH CONTRIBUTIONS BY USING ITS AUTHORIZED CAPITAL.COMPANY'S SHARE CAPITAL IS TO BE INCREASED BY UP TO EUR 0.8 MLN FROM ITS CURRENT LEVEL OF EUR 3.3 MLN TO UP TO EUR 4.1 MLN IN RETURN FOR CASH CONTRIBUTIONS BY ISSUING UP TO 0.8 MLN NEW NO-PAR VALUE REGISTERED SHARES.NEW SHARES WILL BE OFFERED TO EXISTING SHAREHOLDERS AT A RATIO OF 4:1 BY MEANS OF AN INDIRECT SUBSCRIPTION RIGHT .PERIOD DURING WHICH THE NEW SHARES CAN BE SUBSCRIBED STARTS JULY 14, 2017 AND ENDS ON JULY 27, 2017.SUBSCRIPTION PRICE HAS BEEN SET AT EUR 6.10.GROSS PROCEEDS OF UP TO EUR 5 MILLION FROM THIS RIGHTS ISSUE WILL BE USED TO PARTIALLY FINANCE THE ACQUISITION OF THE SERACELL PHARMA AG, BERLIN ("SERACELL").  Full Article

Vita 34 elects new supervisory board members
Thursday, 29 Jun 2017 01:28am EDT 

June 29 (Reuters) - VITA 34 AG :REPORTED ON WEDNESDAY ON ANNUAL GENERAL MEETING AND DIVIDEND DISTRIBUTION.AGM ELECTED FRANK KÖHLER AND STEFFEN RICHTSCHEID AS MEMBERS OF THE SUPERVISORY BOARD.FRANK KÖHLER ELECTED CHAIRMAN OF SUPERVISORY BOARD.  Full Article

Vita 34: elections to Supervisory Board
Wednesday, 28 Jun 2017 09:12am EDT 

June 28 (Reuters) - VITA 34 AG ::AT AGM, SUPERVISORY BOARD'S PROPOSAL TO RESUBMIT THE CHAIRMAN OF THE SUPERVISORY BOARD, HANS GEORG GIERING DID NOT REACH A MAJORITY​​.  Full Article

Vita 34 to cooperate with Romanian Besmax Life Solutions SRL
Tuesday, 27 Jun 2017 01:34am EDT 

June 27 (Reuters) - VITA 34 AG ::DGAP-NEWS: VITA 34 AG SIGNS COOPERATION AGREEMENT WITH ROMANIAN COMPANY BESMAX LIFE SOLUTIONS SRL.‍LONG-TERM PARTNERSHIP IS AIMED AT ACHIEVING A RELEVANT MARKET SHARE IN ROMANIAN MARKET​.  Full Article

Vita 34 ag wins MK Beleggingsmaatschappij Venlo B.V. as new strategic investor
Thursday, 15 Jun 2017 01:22am EDT 

June 15 (Reuters) - VITA 34 AG ::SAID ON WEDNESDAY ACQUIRES MK BELEGGINGSMAATSCHAPPIJ VENLO B.V. AS A NEW STRATEGIC INVESTOR AND SECURES SUPPORT FOR FURTHER CORPORATE ACTION.THROUGH MK BELEGGINGSMAATSCHAPPIJ VENLO B.V., MR. KÖHLER TAKES OVER NEWLY ISSUED SHARES OF UP TO 10% OF THE SHARE CAPITAL.ADDITIONAL BACKSTOP AGREED FOR JUST UNDER EUR 3 MILLION IN CONNECTION WITH THE UPCOMING RIGHTS ISSUE.MK BELEGGINGSMAATSCHAPPIJ VENLO B.V., THE NETHERLANDS (MKBV), WILL HOLD APPROX. 9.1% OF THE SHARE CAPITAL OF VITA 34 AND HAS ALSO AGREED TO SUPPORT VITA 34 IN IMPLEMENTING ITS PLANNED RIGHTS ISSUE.TO ENSURE THE SUCCESS OF THIS RIGHTS ISSUE, MKBV HAS ASSUMED A BACKSTOP OBLIGATION ACCORDING TO WHICH IT WILL TAKE OVER ANY UNSUBSCRIBED NEW SHARES UNDER THIS PLANNED RIGHTS ISSUE UP TO A MAXIMUM AMOUNT OF JUST UNDER EUR 3 MILLION, PROVIDED THE ISSUE PRICE DOES NOT EXCEED EUR 6.50.  Full Article

Vita 34 decides on a capital increase of around 10 pct
Wednesday, 14 Jun 2017 12:41am EDT 

June 14 (Reuters) - VITA 34 AG :DGAP-ADHOC: VITA 34 AG DECIDES ON A CAPITAL INCREASE OF AROUND 10%.STRATEGIC INVESTOR MK BELEGGINGSMAATSCHAPPIJ VENLO B.V. (NETHERLANDS) TO ACQUIRE A STAKE IN VITA 34.ISSUE PRICE OF EUR 6.62.GROSS PROCEEDS OF APPROXIMATELY EUR 2 MILLION FROM THIS PRIVATE PLACEMENT WILL BE USED TO FINANCE PARTS OF THE ACQUISITION OF THE SERACELL AG, BERLIN.  Full Article

Vita 34 updates on planned capital increase and changes in management
Monday, 12 Jun 2017 11:43am EDT 

June 12 (Reuters) - VITA 34 AG :DGAP-ADHOC: VITA 34 AG UPDATES ON PLANNED CAPITAL INCREASE AND CHANGES IN THE MANAGEMENT.PLANS A CAPITAL INCREASE IN AMOUNT OF ABOUT 10 % CLOSE TO CURRENT MARKET PRICE WITH A STRATEGIC INVESTOR TO FINANCE TAKEOVER OF SERACELL PHARMA AG.DISMISSES CHAIRMAN OF MANAGEMENT BOARD, DR. ANDRÉ GERTH, WITH IMMEDIATE EFFECT AND APPOINTS MEMBER OF SUPERVISORY BOARD AND LAWYER, ALEXANDER STARKE, AS A INTERIM MEMBER OF MANAGEMENT BOARD.APPOINTS MEMBER OF MANAGEMENT BOARD, DR. WOLFGANG KNIRSCH, AS NEW CHAIRMAN OF MANAGEMENT BOARD.FURTHER CAPITAL INCREASE WITH SUBSCRIPTION RIGHTS AND ISSUE PROCEEDS IN SCOPE OF UP TO EUR 5 MILLION PLANNED.WILL REVISE FORECAST 2017 FOR VITA GROUP IN COMING WEEKS.  Full Article

BRIEF-Vita 34 H1 net result swings to loss of EUR 1.0 mln

* H1 REVENUE INCREASED BY 2.5 PERCENT AND GROSS PROFIT BY 14 PERCENT AS COMPARED WITH H1 2016